Home › NDC Lookup › RxCUI directory › RxCUI 617995

12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet — RxCUI 617995

RxNorm drug concept · Semantic clinical drug
RxCUI 617995 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI617995
Official name12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamoxicillin 1000 MG / clavulanate potassium 62.5 MG 12HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)5,048 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amoxicillin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amoxicillin treats bacterial infections — things like ear infections, strep throat, sinus infections, certain respiratory infections, skin infections, and urinary tract infections....
  • What kinds of infections does amoxicillin actually treat?
  • Yes — absolutely finish the full course. Feeling better doesn't mean all the bacteria are gone. If you stop early, any remaining bacteria can rebound, and they may be harder to tre...
  • Do I have to take the whole course even if I feel better after a few days?
📖 Read our full Amoxicillin guide →

🕸️ Concept Web — How 12 HR amoxicillin 1000 MG / clavulanate 62.5 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet RxCUI 617995

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Amoxicillin 723
    • Clavulanate 48203
    • Amoxicillin / clavulanate 19711
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Augmentin 151392
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amoxicillin / clavulanate Extended Release Oral Tablet 617988
    • Amoxicillin / clavulanate Oral Product 1152874
    • Amoxicillin / clavulanate Pill 1152875
    • Amoxicillin / clavulanate Extended Release Oral Tablet [Augmentin] 618038
    • Augmentin Oral Product 1174307
    • Augmentin Pill 1174308
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amoxicillin 1000 MG 331055
    • Clavulanate 62.5 MG 617303
    • 12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet [Augmentin] 861689
    • Amoxicillin 1000 MG / clavulanate 62.5 MG [Augmentin] 618037

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amoxicillin 1000 MG SCDC · 331055
  • Clavulanate 62.5 MG SCDC · 617303
  • Amoxicillin / clavulanate Extended Release Oral Tablet SCDF · 617988
  • Amoxicillin / clavulanate Oral Product SCDG · 1152874
  • Amoxicillin / clavulanate Pill SCDG · 1152875

Brand-Name Concepts

  • 12 HR amoxicillin 1000 MG / clavulanate 62.5 MG Extended Release Oral Tablet [Augmentin] SBD · 861689
  • Amoxicillin 1000 MG / clavulanate 62.5 MG [Augmentin] SBDC · 618037
  • Amoxicillin / clavulanate Extended Release Oral Tablet [Augmentin] SBDF · 618038
  • Augmentin Oral Product SBDG · 1174307
  • Augmentin Pill SBDG · 1174308
  • Augmentin BN · 151392

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 617995 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00781-1943-39 40 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0781-19... Amoxicillin and Clavulanate Potassium Sandoz Inc 2010-04-21
00781-1943-82 28 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0781-19... Amoxicillin and Clavulanate Potassium Sandoz Inc 2010-04-21
85766-0123-28 28 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (85766-1... Amoxicillin and Clavulanate Potassium Sportpharm LLC 2025-11-06
Observed labelers: Sandoz Inc (2) · Sportpharm LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$5.9206
Range $5.9206–$5.9206 · middle 50% $5.9206–$5.9206 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.